Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
César U. Monjarás-Ávila, Ana C. Lorenzo‐Leal, Ana C. Luque-Badillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7946-7946
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment
Gorka Larrinaga, Miriam Redrado, Ana Loizaga‐Iriarte, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 1
F-box protein FBXO21 overexpression inhibits the proliferation and metastasis of clear cell renal cell carcinoma and is closely related to the CREB pathway and tumor immune cell infiltration
Wuping Yang, Taile Jing, Cunjin Wu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Targeting apoptosis in clear cell renal cell carcinoma
Adam Kowalewski, Jędrzej Borowczak, Mateusz Maniewski, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116805-116805
Open Access | Times Cited: 5
GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
Dazhi Wang, Iqbal Mahmud, Vijay S. Thakur, et al.
Cancer Research (2024) Vol. 84, Iss. 13, pp. 2141-2154
Closed Access | Times Cited: 4
Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma
Simone C. Kleinendorst, Egbert Oosterwijk, Janneke D.M. Molkenboer‐Kuenen, et al.
Theranostics (2024) Vol. 14, Iss. 9, pp. 3693-3707
Open Access | Times Cited: 4
Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives
S. Rajkumari, Jaspreet Singh, Usha Agrawal, et al.
International Immunopharmacology (2024) Vol. 142, pp. 112949-112949
Closed Access | Times Cited: 4
The Role and Mechanisms of Aurora Kinases in Kidney Diseases
Mei‐Ying Chang, Qiuyi Li, Zhonghong Shi, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Optical genome and epigenome mapping of clear cell renal cell carcinoma
Sapir Margalit, Zuzana Tulpová, Yael Michaeli, et al.
NAR Cancer (2025) Vol. 7, Iss. 1
Open Access
Versatile roles of Annexin A4 in ccRCC: impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment
Maximilian Wess, Manuel Rogg, Constance Gueib-Picard, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112198-112198
Open Access
Study on the mechanism of BGN in progression and metastasis of ccRCC
Hanqing Xia, Tianzhen He, Xueyu Li, et al.
BMC Medical Genomics (2025) Vol. 18, Iss. 1
Open Access
The Role of Perirenal Adipose Tissue in Carcinogenesis—From Molecular Mechanism to Therapeutic Perspectives
Adriana Grigoraş, Cornelia Amălinei
Cancers (2025) Vol. 17, Iss. 7, pp. 1077-1077
Open Access
Identification and validation of molecular subtypes and prognostic models in patients with kidney cancer based on differential genes based on B cells: a multiomics analysis
Jiaao Sun, Shiyan Song, Qiancheng Ma, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Multi-omics analysis identifies DLX4 as a novel biomarker for diagnosis, prognosis, and immune infiltration: from pan-cancer to renal cancer
Zengshun Kou, Shuaizhi Zhu, Jiaxi Zhu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Kynurenine Pathway after Kidney Transplantation: Friend or Foe?
Izabela Zakrocka, Ewa M. Urbańska, Wojciech Załuska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9940-9940
Open Access | Times Cited: 2
Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma
Shuang Liu
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma
Qing Lu, Ping Xi, Suling Xu, et al.
Aging (2024)
Open Access | Times Cited: 2
A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma
Wei He, Zixiang Cong, Chengtao Niu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma
Alvira Ajadee, Sabkat Mahmud, Md Bayazid Hossain, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0310843-e0310843
Open Access | Times Cited: 2
Potential involvement of cuproptosis induced by m6A-modified autophagy gene ATG10 in KICH
Qingyun Zhu, Daiquan Fu, Zhaohui Zhu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Extranodal lymphoma: pathogenesis, diagnosis and treatment
Hua Yang, Yang Xun, Chao Ke, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 6
A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC
Longlong Dai, Daen Pan, Jiafei Jin, et al.
Aging (2024) Vol. 16, Iss. 6, pp. 5149-5162
Open Access | Times Cited: 1
Extremely Low-Frequency Electromagnetic Field (ELF-EMF) Induced Alterations in Gene Expression and Cytokine Secretion in Clear Cell Renal Carcinoma Cells
Aleksandra Cios, Martyna Ciepielak, Krystyna Lieto, et al.
Medycyna Pracy (2024) Vol. 75, Iss. 2, pp. 133-141
Open Access | Times Cited: 1
Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma
Enrico Sammarco, Martina Rossetti, Alessia Salfi, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Open Access | Times Cited: 1
Vasculogenic Mimicry-Related Gene Prognostic Index for Predicting Prognosis, Immune Microenvironment in Clear Cell Renal Cell Carcinoma
Junyong Ou, Haoming Yin, Fan Shu, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e36235-e36235
Open Access | Times Cited: 1
Nc‐RNA‐mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
Xinyi Zeng, Shen Du, Lou Geng, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top